United States · FDA National Drug Code directory
Cymbalta
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-3240_aa5061b1-f237-425a-9d05-575c333dfd37
- Product NDC
- 0002-3240
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Duloxetine hydrochloride
- Labeler
- Eli Lilly and Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20040824 / 20261002
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →